Lysophosphatidic Acid Receptor 3 Activation Is Involved in the Regulation of Ferroptosis

Area of Science:

• Biochemistry
• Cell Biology
• Physiology

Background:

• Ferroptosis, a programmed cell death driven by lipid peroxidation and iron, is implicated in erythropoiesis and aging.
• Lysophosphatidic acid receptor 3 (LPA3) activation has previously shown protective effects against oxidative stress and anemia recovery.

Purpose of the Study:

• To investigate the role of LPA3 activation in regulating ferroptosis.
• To determine if LPA3 activation can modulate iron metabolism and lipid peroxidation in ferroptosis.

Main Methods:

• Utilized an LPA3 agonist (OMPT) and LPAR3 siRNA in erastin-induced ferroptosis models.
• Assessed ferroptosis markers, lipid peroxidation, intracellular iron, and NRF2 expression.
• Evaluated erythropoiesis defects in K562 cells using a luciferase assay.

Main Results:

• OMPT treatment upregulated anti-ferroptosis genes (SLC7A11, GPX4, HO-1, FTH1) and NRF2.
• OMPT reduced lipid peroxidation and intracellular iron accumulation.
• LPA3 activation rescued erastin-induced erythropoiesis defects in K562 cells.

Conclusions:

• LPA3 activation inhibits ferroptosis by suppressing lipid oxidation and iron accumulation.
• LPA3 activation plays a critical role in mitigating ferroptosis in erythroid cells.
• Ferroptosis may represent a molecular link between LPA3 signaling, erythropoiesis, and aging processes.